体内
新陈代谢
代谢物
药物代谢
生物
肝细胞
孵化
生物化学
活性代谢物
体外
药代动力学
药理学
化学
生物技术
作者
G W Sandker,R.M.E. Vos,L. P. C. Delbressine,Maarten J. H. Slooff,Dirk K. F. Meijer,Geny M. M. Groothuis
出处
期刊:Xenobiotica
[Taylor & Francis]
日期:1994-01-01
卷期号:24 (2): 143-155
被引量:65
标识
DOI:10.3109/00498259409043228
摘要
1. The metabolism of the three drugs (Org GB 94, Org 3770 and Org OD 14) was studied in isolated human and rat hepatocytes. The metabolic profiles in rat and human hepatocytes were compared with the available in vivo data in both species.2. All three drugs were metabolized extensively under the conditions used, both in human and rat hepatocytes, showing both extensive phase I and II metabolism.3. During 3-h incubation with rat hepatocytes the three compounds were metabolized completely, whereas incubation with human hepatocytes only resulted in partial metabolism, amounting for 58% (Org GB 94), 36% (Org 3770) and 94% (Org OD 14) of the dose. In addition, rat hepatocytes excreted relatively more of the formed metabolites than human hepatocytes.4. For both species, the metabolites formed in the isolated cells were quite similar to those found in vivo. With respect to Org GB 94 and Org 3770, metabolites were detected in man in vivo and in isolated human hepatocytes that were not found in any of the animal species studied previously.5. The reflection of interspecies differences in isolated hepatocytes, with respect to borh metabolite profiles and human-specific metabolites, renders isolated human hepatocytes a very valuable tool during preclinical drug development.
科研通智能强力驱动
Strongly Powered by AbleSci AI